-
Mashup Score: 22022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - 2 year(s) ago
Welcome to the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR…please wait while the program loads.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
PURPOSE Hematopoietic cell transplantation (HCT) is curative for hematologic disorders, but outcomes are historically inferior when using HLA-mismatched donors. Despite unrelated donor registries listing > 38 million volunteers, 25%-80% of US patients lack an HLA-matched unrelated donor, with significant disparity across ethnic groups. We hypothesized that HCT with a mismatched unrelated donor…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Congrats to co-first author @amjimenezmd of @SylvesterCancer, Bronwen Shaw, @DrStevenDevine and team. A landmark study! NMDP Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide https://t.co/m4YS1UFMLF
-
-
Mashup Score: 0
Antonio Jimenez, MD, Sylvester Comprehensive Cancer Center, Miami Springs, FL, discusses a study aiming to evaluate the prognostic ability of…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Novel classification system based on CIBMTR data to predict post-transplant outcomes in #AML Hear more from @amjimenezmd (@SylvesterCancer): https://t.co/JhgXhodaqs #ASH2020 @ASH_hematology #HemOnc #BMTsm #Leukemia #Leusm #AMLsm
-
-
Mashup Score: 0
Impact of Pre-Transplant Molecular Measurable Residual Disease (MMRD) and Europ…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Our work highlighted by @AML_Hub. Molecular minimal residual disease continues to be an important prognostic factor in AML patient undergoing allo-HCT. Honored to have mentors like @drkomanduri and @amjimenezmd @SylvesterCancer #TCTM21 @UAZCancer https://t.co/G53ANQRE59 https://t.co/SbAsg0ulh0
-
-
Mashup Score: 0Miami Nights 2020 - 4 year(s) ago
Join us as we turn up the heat from the heart of Sylvester Comprehensive Cancer Center!
Source: Miami Nights 2020Categories: Hem/Oncs, Latest HeadlinesTweet-
I'm attending Miami Nights 2020. Looking forward to connect with my mentors and friends @drkomanduri @Drjhoffmanmiami @amjimenezmd https://t.co/jlkc3SkRRx
-
Welcome to the last day of the 2022 Tandem Meetings. Make sure to add Plenary Session 5 and 6 to your schedule. #Tandem22 @CIBMTR @amjimenezmd @DrStevenDevine @AlanHanash Click the link below to find out times and locations: https://t.co/K73b0zTQvZ https://t.co/KS5dQqT6NF